Cargando…

Tianxiangdan Improves Coronary Microvascular Dysfunction in Rats by Inhibiting Microvascular Inflammation via Nrf2 Activation

BACKGROUND: Tianxiangdan (TXD) is used in traditional Chinese medicine because of its therapeutic and preventive effects in the treatment of coronary heart disease. However, the underlying mechanism of TXD in coronary microvascular disease (CMD) remains unclear. METHODS: A rat model of CMD was devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawuer, Guligena, Ma, Xue-Kuan, Zhang, Ya-Jie, Zhang, Xuan-Ming, Ainiwaer, Zulihumaer, An, Dong-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660204/ https://www.ncbi.nlm.nih.gov/pubmed/34899948 http://dx.doi.org/10.1155/2021/4114784

Ejemplares similares

Inflammation in Coronary Microvascular Dysfunction
por: Sagris, Marios, et al.
Publicado: (2021)

Coronary Microvascular Dysfunction: Linking Inflammation and Cardiac Dysfunction?
por: Schindler, Thomas H., et al.
Publicado: (2023)

Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction
por: Godo, Shigeo, et al.
Publicado: (2021)

Coronary Microvascular Dysfunction
por: Vancheri, Federico, et al.
Publicado: (2020)

Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases
por: Zanatta, Elisabetta, et al.
Publicado: (2019)

Coronary microvascular dysfunction in diabetes mellitus
por: Kibel, Aleksandar, et al.
Publicado: (2017)

Invasive evaluation of coronary microvascular dysfunction
por: Travieso, Alejandro, et al.
Publicado: (2022)

Circulating Biomarkers in Coronary Microvascular Dysfunction
por: Chakrala, Teja, et al.
Publicado: (2023)

Systemic microvascular dysfunction in microvascular and vasospastic angina
por: Ford, Thomas J, et al.
Publicado: (2018)

Coronary Microvascular Dysfunction in HIV: A Review
por: Rethy, Leah, et al.
Publicado: (2019)

Experimental animal models of coronary microvascular dysfunction
por: Sorop, Oana, et al.
Publicado: (2020)

Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus
por: Weber, Brittany N., et al.
Publicado: (2021)

Epicardial adipose tissue in coronary microvascular dysfunction
por: Duyuler, Serkan, et al.
Publicado: (2022)

Noninvasive Functional Evaluation of Coronary Microvascular Dysfunction
por: Park, Jin-Sun
Publicado: (2021)

Classification, Diagnosis, and Treatment of Coronary Microvascular Dysfunction
por: Sucato, Vincenzo, et al.
Publicado: (2022)

Bibliometric and visual analysis of coronary microvascular dysfunction
por: Lin, Xiaoxiao, et al.
Publicado: (2022)

Phenotype-based management of coronary microvascular dysfunction
por: Ang, Daniel Tze Yee, et al.
Publicado: (2022)

Sex differences in contributors to coronary microvascular dysfunction
por: Kwan, Alan C., et al.
Publicado: (2023)

Coronary microvascular dysfunction in heart failure patients
por: Toya, Takumi, et al.
Publicado: (2023)

Coronary Microvascular Dysfunction: Features and Prognostic Value
por: Kopeva, Kristina, et al.
Publicado: (2023)

Endothelial Autophagy in Coronary Microvascular Dysfunction and Cardiovascular Disease
por: Zhao, Fujie, et al.
Publicado: (2022)

Vitamin C and Microvascular Dysfunction in Systemic Inflammation
por: Tyml, Karel
Publicado: (2017)

Clinical characteristics and biomarkers of coronary microvascular dysfunction and obstructive coronary artery disease
por: Mayala, Henry Anselmo, et al.
Publicado: (2019)

Coronary Microvascular Dysfunction and the Role of Noninvasive Cardiovascular Imaging
por: Ayub, Muhammad Talha, et al.
Publicado: (2020)

Coronary Microvascular Dysfunction: PET, CMR and CT Assessment
por: Tonet, Elisabetta, et al.
Publicado: (2021)

Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD
por: Elbaum, Lindsay, et al.
Publicado: (2022)

Association of Inflammation and Endothelial Dysfunction with Coronary Microvascular Resistance in Patients with Cardiac Syndrome X
por: Long, Ming, et al.
Publicado: (2017)

Standard exercise stress testing attenuates peripheral microvascular function in patients with suspected coronary microvascular dysfunction
por: Nardone, Massimo, et al.
Publicado: (2021)

Effect of Proprietary Chinese Medicine on Coronary Microvascular Dysfunction in Patients with Microvascular Angina: A Systematic Review and Meta-Analysis
por: Yu, Qiuyu, et al.
Publicado: (2023)

Coronary Microvascular Disease
por: Thakker, Ravi A., et al.
Publicado: (2022)

Effects of Tianxiangdan Granule treatment on atherosclerosis via NF-κB and p38 MAPK signaling pathways
por: Sun, Long-Fei, et al.
Publicado: (2018)

Relationship Between Risk of Atherosclerotic Cardiovascular Disease, Inflammation, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis
por: Weber, Brittany, et al.
Publicado: (2022)

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction
por: Ford, Thomas J, et al.
Publicado: (2020)

Physiological Stratification of Patients With Angina Due to Coronary Microvascular Dysfunction
por: Rahman, Haseeb, et al.
Publicado: (2020)

Angina due to obstructive coronary artery disease and microvascular dysfunction
por: Crea, Filippo
Publicado: (2019)

Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction
por: Lindner, Jonathan R., et al.
Publicado: (2021)

Findings suggestive of coronary microvascular dysfunction in cats with myocardial ischemia
por: Belerenian, Guillermo, et al.
Publicado: (2021)

Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction
por: Zheng, Zhaohai, et al.
Publicado: (2022)

Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound
por: Zhan, Junzhen, et al.
Publicado: (2022)

Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know
por: Marano, Paul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tu17i9mn6k261nqkmkgqcid7gg